The cellular-differential composition of the intestinal epithelium in various phases of inflammatory bowel diseases
- Authors: Bernardelli L.I.1, Indeickin F.A.2, Matyusheva L.G.1, Emelin A.M.3, Skalinskaya M.I.1, Nekrasova A.S.1, Deev R.V.3
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- National Center for Clinical Morphological Diagnostics
- Petrovsky National Research Centre of Surgery
- Issue: Vol 162, No 2 (2024)
- Pages: 127-139
- Section: Original Study Articles
- Submitted: 16.06.2024
- Accepted: 19.07.2024
- Published: 10.11.2024
- URL: https://j-morphology.com/1026-3543/article/view/633461
- DOI: https://doi.org/10.17816/morph.633461
- ID: 633461
Cite item
Abstract
BACKGROUND: The steady increase in the number of inflammatory bowel diseases and the absence of reliably significant diagnostic markers require the search for new morphological criteria for differential diagnosis.
AIM: This study aimed to determine the cellular-differential composition of the intestinal epithelium in the phases of exacerbation and remission in Crohn’s disease and ulcerative colitis.
MATERIALS AND METHODS: Tissue samples of 60 patients with inflammatory bowel diseases (Crohn’s disease, n=30; ulcerative colitis, n=30) and with irritable bowel syndrome (control group, n=15) were studied using histological, immunohistochemical, morphometric and statistical methods.
RESULTS: Distinct features of the cellular-differential composition of the epithelium in the mucous membrane of the ileum, ascending colon, sigmoid colon, and rectum were identified across these conditions, with differences observed during exacerbation and remission in inflammatory bowel diseases. The proportion of goblet cells in the epithelial lining varied by intestinal region and disease type and phase.
Goblet cell differentiation: 25.0% more goblet cells of the superficial epithelium between the crypts of the ileum in acute Crohn’s disease compared with remission (p=0.0002); 42.9% more goblet cells in the superficial epithelium of the ascending colon compared with irritable bowel syndrome (p=0.0001); 23.0% more goblet cells crypt in the sigmoid colon compared with ulcerative colitis in the acute stage (p=0.0024). There were no significant differences in the differentiation of Paneth cells. There was a threefold increase in endocrinocytes in the sigmoid colon in acute Crohn’s disease compared with irritable bowel syndrome (p=0.0238).
Nonepithelial differon cells: fewer interepithelial lymphocytes in Crohn’s disease in remission compared with Crohn’s disease in the acute stage by 2.4 times in the sigmoid colon, 4.0 times in the rectum (p <0,0001); compared with irritable bowel syndrome by 4.8 times in the ileum, 2.7 times in the ascending intestine, 4.0 times in the sigmoid colon (p <0,05); 8.0 times in the rectum compared with ulcerative colitis in remission (p=0,0004). Additionally, the study found proliferative activity of crypt cells (mainly goblet-shaped) increased by 4.2 times in the sigmoid colon in acute Crohn’s disease compared with acute ulcerative colitis (p=0,0016).
CONCLUSIONS: Morphometric parameters of the cellular-differential composition of the intestinal epithelium can serve as potential differential diagnostic criteria. Acute Crohn’s disease is characterized by a higher proliferation index in the sigmoid colon compared with acute ulcerative colitis, while Crohn’s disease in remission shows a lower number of interepithelial lymphocytes in the rectum compared with ulcerative colitis in remission.
Full Text

About the authors
Liudmila I. Bernardelli
North-Western State Medical University named after I.I. Mechnikov
Email: bernardellimila@gmail.com
ORCID iD: 0000-0001-9077-7718
SPIN-code: 5671-1891
doctor
Russian Federation, 47 Piskarevsky Prospekt, 195067 Saint PetersburgFedor A. Indeickin
National Center for Clinical Morphological Diagnostics
Email: f.indeickin@yandex.ru
ORCID iD: 0000-0002-1436-2235
SPIN-code: 4627-4445
doctor of pathological anatomy
Russian Federation, Saint PetersburgLilia G. Matyusheva
North-Western State Medical University named after I.I. Mechnikov
Email: liliali2719@gmail.com
ORCID iD: 0000-0003-1746-8059
SPIN-code: 3658-3376
student of the faculty of Preventive Medicine
Russian Federation, 47 Piskarevsky Prospekt, 195067 Saint PetersburgAlexey M. Emelin
Petrovsky National Research Centre of Surgery
Email: eamar40rn@gmail.com
ORCID iD: 0000-0003-4109-0105
SPIN-code: 5605-1140
doctor of pathological anatomy
Russian Federation, MoscowMaria I. Skalinskaya
North-Western State Medical University named after I.I. Mechnikov
Email: Mariya.Skalinskaya@szgmu.ru
ORCID iD: 0000-0003-0769-8176
SPIN-code: 2596-5555
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, 47 Piskarevsky Prospekt, 195067 Saint PetersburgAnna S. Nekrasova
North-Western State Medical University named after I.I. Mechnikov
Email: Anna.Nekrasova@szgmu.ru
ORCID iD: 0000-0001-5198-9902
SPIN-code: 7502-5036
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, 47 Piskarevsky Prospekt, 195067 Saint PetersburgRoman V. Deev
Petrovsky National Research Centre of Surgery
Author for correspondence.
Email: romdey@gmail.com
ORCID iD: 0000-0001-8389-3841
SPIN-code: 2957-1687
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, MoscowReferences
- Ocansey DKW, Wang L, Wang J, et al. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med. 2019;8(1):31. doi: 10.1186/s40169-019-0251-8
- Maev IV, Shelygin YuA, Skalinskaya MI, et al. The pathomorphosis of inflammatory bowel diseases. Annals of the Russian Academy of Medical Sciences. 2020;75(1):27–35. EDN: FWJIAO doi: 10.15690/vramn1219
- Tkachev AV, Mkrtchyan LS, Mazovka KE, Bohanova EG. In the labyrinths of pathogenesis: the environment and metamorphosis of IBD. South Russian Journal of Therapeutic Practice. 2021;2(3):30–39. EDN: KZOSKG doi: 10.21886/2712-8156-2021-2-3-30-39
- Kononova YA, Likhonosov NP, Babenko AY. Metformin: expanding the scope of application-starting earlier than yesterday, canceling later. Int J Mol Sci. 2022;23(4):2363. doi: 10.3390/ijms23042363
- Yu Y, Yang W, Li Y, Cong Y. Enteroendocrine cells: sensing gut microbiota and regulating inflammatory bowel diseases. Inflamm Bowel Dis. 2020;26(1):11–20. doi: 10.1093/ibd/izz217
- Ocansey DKW, Zhang L, Wang Y, et al. Exosome-mediated effects and applications in inflammatory bowel disease. Biol Rev Camb Philos Soc. 2020;95(5):1287–1307. doi: 10.1111/brv.12608
- Fernández-Tomé S, Ortega Moreno L, Chaparro M, Gisbert JP. Gut microbiota and dietary factors as modulators of the mucus layer in inflammatory bowel disease. Int J Mol Sci. 2021;22(19):10224. doi: 10.3390/ijms221910224
- Kovaleva AL, Poluektova EA, Shifrin OS. Intestinal barrier, permeability and nonspecific inflammation in functional gastrointestinal disorders. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):52–59. EDN: EAPBNM doi: 10.22416/1382-4376-2020-30-4-52-59
- Ng QX, Soh AYS, Loke W, et al. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;11:345–349. doi: 10.2147/JIR.S174982
- Kirsch R, Riddell R. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19(12):1638–1645. Corrected and republished from: Mod Pathol. 2007;20(2):278. doi: 10.1038/modpathol.3800704
- Lockhart A, Mucida D, Bilate AM. Intraepithelial Lymphocytes of the Intestine. Annu Rev Immunol. 2024;42(1):289–316. doi: 10.1146/annurev-immunol-090222-100246
- Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A review of inflammatory bowel disease: a model of microbial, immune and neuropsychological integration. Public Health Rev. 2021;42:1603990. doi: 10.3389/phrs.2021.1603990
- Sharapov IY, Kvaratskheliiya AG, Bolgucheva MB, Korotkikh KN. Functional morphology of goblet cells of the small intestine under the influence of various factors. Journal of Anatomy and Histopathology. 2021;10(2):73–79. EDN: NEDOPW doi: 10.18499/2225-7357-2021-10-2-73-79
- Churkova ML, Kostyukevich SV. The epithelium mucosal of colon in normal and in functional and inflammatory bowel diseases. Experimental and Clinical Gastroenterology Journal. 2018;(5):128–132. EDN: XZJCPJ
- Mavlikeev MO, Arkhipova SS, Chernova ON, et al. A short course in histological technique. Kazan: Kazan University; 2020. 107 р. (In Russ.)
- Kononov AV, Mozgovoy SI, Shimanskaya AG. Lifetime pathologic and anatomical diagnosis of diseases of the digestive system (class XI ICD-10). Clinical recommendations RPS3.11(2018). Moscow: Practical medicine; 2019. 191 р. (In Russ.)
- Ivashkin VT, Shelygin YuA, Abdulganieva DI, et al. Crohn’s disease. Clinical recommendations (preliminary version). Koloproktologia. 2020;19(2):8–38. EDN: AGKJNF doi: 10.33878/2073-7556-2020-19-2-8-38
- General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14–18.
- Singh V, Johnson K, Yin J, et al. Chronic inflammation in ulcerative colitis causes long-term changes in goblet cell function. Cell Mol Gastroenterol Hepatol. 2022;13(1):219–232. doi: 10.1016/j.jcmgh.2021.08.010
- Kang Y, Park H, Choe BH, Kang B. The role and function of mucins and its relationship to inflammatory bowel disease. Front Med (Lausanne). 2022;9:848344. doi: 10.3389/fmed.2022.848344
- Zolotova NA, Akhrieva KM., Zayratyants OV. Epithelial barrier of the colon in health and patients with ulcerative colitis. Experimental and Clinical Gastroenterology Journal. 2019;(2):4–13. EDN: SUBULS doi: 10.31146/1682-8658-ecg-162-2-4-13
- Rezzani R, Franco C, Franceschetti L, et al. A focus on enterochromaffin cells among the enteroendocrine cells: localization, morphology, and role. Int J Mol Sci. 2022;23(7):3758. doi: 10.3390/ijms23073758
- Tao E, Zhu Z, Hu C, et al. Potential roles of enterochromaffin cells in early life stress-induced irritable bowel syndrome. Front Cell Neurosci. 2022;16:837166. doi: 10.3389/fncel.2022.837166
- Knyazev OV, Shkurko TV, Fadeyeva NA, et al. Epidemiology of chronic inflammatory bowel disease. Yesterday, today, tomorrow. Experimental and Clinical Gastroenterology Journal. 2017;(3):4–12. EDN: ZRPJFX
Supplementary files
